Reagan-Udall Foundation for the Food and Drug Administration Inc (EIN 263727917) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2009

Legal Domicile

Principal Officer

Susan C Winckler

Phone

2028492075

Tax Period

2024-01-01 to 2024-12-31

Reagan-Udall Foundation for the Food and Drug Administration Inc, founded in 2009, is a community nonprofit that reported $8.2M in total revenue in fiscal year 2024. Expenses of $7.9M left a modest 4% surplus.

Mission

Advance the mission of the Food and Drug Administration to modernize product development, accelerate innovation, and enhance product safety.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $4,788,188

Program Service Revenue $3,407,304

Investment Income $167,709

Other Revenue $-121,627

TOTAL REVENUE $8,241,574

Expense Breakdown

Grants Paid $0

Salaries & Benefits $3,351,164

Fundraising Expenses $140,488

Program Expenses $7,485,122

Other Expenses $4,528,975

TOTAL EXPENSES $7,880,139

Year-over-Year Comparison

	2024	2023	Change
Revenue	$8,241,574	$8,216,727	+0.0%
Expenses	$7,880,139	$7,790,276	+0.0%
Net Income	$361,435	$426,451	-0.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$748,296

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Richard L Schilsky	Board Chair	4.00	Officer Director	$0	$0	$0
Adrian F Hernandez	Board Vice Chair	4.00	Officer Director	$0	$0	$0
Debra L Ness	Treasurer	4.00	Officer Director	$0	$0	$0
Lynne Zydowsky	Secretary	4.00	Officer Director	$0	$0	$0
Edward J Allera	Director	4.00	Director	$0	$0	$0
Christie Boutte	Director	4.00	Director	$0	$0	$0
Phil Febbo	Director	4.00	Director	$0	$0	$0
David C Fajgenbaum	Director	4.00	Director	$0	$0	$0
William N Hait	Director	4.00	Director	$0	$0	$0
James EK Hildreth	Director	4.00	Director	$0	$0	$0
Esther Krofah	Director	4.00	Director	$0	$0	$0
Phuong Khanh PK Morrow	Director	4.00	Director	$0	$0	$0
Richard Moscicki	Director	4.00	Director	$0	$0	$0
Reed V Tuckson	Director	4.00	Director	$0	$0	$0
Pietro Antonio Tataranni	Director	4.00	Director	$0	$0	$0
Andrew C von Eschenbach	Director	4.00	Director	$0	$0	$0
Sumbul Desai	Director	4.00	Director	$0	$0	$0
Susan C Winckler RPh JD	Chief Executive Officer	40.00	Officer	$448,815	$38,316	$487,131
Amar Bhat PhD	Chief Operating Officer	40.00	Officer	$227,004	$34,161	$261,165
Carla Rodriguez-Watson PhD	Director, Research	40.00	Highest	$221,228	$25,657	$246,885
Lea Ann Browning-McNee MA	Director, Communication and Stakeholder Engagement	40.00	Highest	$185,985	$31,595	$217,580
David E Woodbury Jr MBA	Director, Operations	40.00	Highest	$172,960	$32,298	$205,258
Carolyn Hiller	Senior Advisor for Innovation and Strategic Partne	40.00	Highest	$164,513	$31,660	$196,173
Esther Boadi	Engagement Manager	40.00	Highest	$121,425	$16,216	$137,641

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$8,241,574	$7,880,139	$7,237,733	$361,435
2023	$8,216,727	$7,790,276	$6,385,158	$426,451
2022	$8,752,229	$8,633,422	$8,144,687	$118,807
2021	$5,435,911	$5,303,683	$4,910,430	$132,228
2020	$4,858,127	$4,442,490	$5,042,218	$415,637
2019	$2,778,525	$2,521,247	$4,065,358	$257,278
2018	$2,433,027	$1,847,661	$3,164,298	$585,366

Reagan-Udall Foundation for the Food and Drug Administration Inc